. . "Cardiovascular risk of antipsychotic treatment"@en . . "RIV/00216208:11150/06:00004156" . "6" . "0862-8947" . . . . . . "Mal\u00FD, Radovan" . "Masopust, Ji\u0159\u00ED" . "T\u016Fma, Ivan" . "Cardiovascular risk of antipsychotic treatment"@en . . . "sschizophrenia; antipsychotics; cardiovascular disease; torsades de pointes; myocarditis; cardiomyopathy"@en . . "Kardiovaskul\u00E1rn\u00ED komorbidita je u nemocn\u00FDch se schizofreni\u00ED podce\u0148ov\u00E1na. Nemocn\u00ED trp\u00EDc\u00ED schizofreni\u00ED maj\u00ED vy\u0161\u0161\u00ED riziko rozvoje kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED, je proto nutn\u00E9 vy\u0161et\u0159ovat u t\u011Bchto pac. stav kardiovaskul\u00E1rn\u00EDho syst\u00E9mu a monitorovat jejich t\u011Blesn\u00E9 zdrav\u00ED. Nemocn\u00ED se schizofreni\u00ED jsou ohro\u017Eeni \u010Dast\u011Bj\u0161\u00ED p\u0159\u00EDtomnost\u00ED faktor\u016F rizikov\u00FDch pro rozvoj kardiovask.chorob. Pat\u0159\u00ED mezi n\u011B obezita,kou\u0159en\u00ED, hypertenze. dyslipid\u00E9mie a diabetes mellitus 2. typu. V posledn\u00ED dob\u011B se pozornost soust\u0159edila na skute\u010Dnost, \u017Ee n\u011Bkter\u00E1 antipsychotika mohou prodlu\u017Eovat QT interval s rizikem vzniku arytmi\u00ED torsades de pointes a n\u00E1hl\u00E9 smrti. Mezi faktory zvy\u0161uj\u00EDc\u00ED riziko torsades de pointes pat\u0159\u00ED bradykardie, miner\u00E1lov\u00E1 dysbalance, \u017Eensk\u00E9 pohlav\u00ED a polyfarmakoterapie. Antipsychotiky zp\u016Fsoben\u00E9 torsades de pointes mohou m\u00EDt let\u00E1ln\u00ED n\u00E1sledky. Myokarditidy a kardiomyopatie jsou vz\u00E1cn\u00E9 popisovan\u00E9 komplikace l\u00E9\u010Dby antipsychotiky." . "11150" . . . . "Kardiovaskul\u00E1rn\u00ED rizkika l\u00E9\u010Dby antipsychotiky"@cs . "Kardiovaskul\u00E1rn\u00ED rizkika l\u00E9\u010Dby antipsychotiky" . "RIV/00216208:11150/06:00004156!RIV07-MSM-11150___" . "481457" . "Kardiovaskul\u00E1rn\u00ED komorbidita je u nemocn\u00FDch se schizofreni\u00ED podce\u0148ov\u00E1na. Nemocn\u00ED trp\u00EDc\u00ED schizofreni\u00ED maj\u00ED vy\u0161\u0161\u00ED riziko rozvoje kardiovaskul\u00E1rn\u00EDch onemocn\u011Bn\u00ED, je proto nutn\u00E9 vy\u0161et\u0159ovat u t\u011Bchto pac. stav kardiovaskul\u00E1rn\u00EDho syst\u00E9mu a monitorovat jejich t\u011Blesn\u00E9 zdrav\u00ED. Nemocn\u00ED se schizofreni\u00ED jsou ohro\u017Eeni \u010Dast\u011Bj\u0161\u00ED p\u0159\u00EDtomnost\u00ED faktor\u016F rizikov\u00FDch pro rozvoj kardiovask.chorob. Pat\u0159\u00ED mezi n\u011B obezita,kou\u0159en\u00ED, hypertenze. dyslipid\u00E9mie a diabetes mellitus 2. typu. V posledn\u00ED dob\u011B se pozornost soust\u0159edila na skute\u010Dnost, \u017Ee n\u011Bkter\u00E1 antipsychotika mohou prodlu\u017Eovat QT interval s rizikem vzniku arytmi\u00ED torsades de pointes a n\u00E1hl\u00E9 smrti. Mezi faktory zvy\u0161uj\u00EDc\u00ED riziko torsades de pointes pat\u0159\u00ED bradykardie, miner\u00E1lov\u00E1 dysbalance, \u017Eensk\u00E9 pohlav\u00ED a polyfarmakoterapie. Antipsychotiky zp\u016Fsoben\u00E9 torsades de pointes mohou m\u00EDt let\u00E1ln\u00ED n\u00E1sledky. Myokarditidy a kardiomyopatie jsou vz\u00E1cn\u00E9 popisovan\u00E9 komplikace l\u00E9\u010Dby antipsychotiky."@cs . . "16" . . "Kardiovaskul\u00E1rn\u00ED rizkika l\u00E9\u010Dby antipsychotiky" . "587;593" . "7"^^ . . "The cardiovascular comorbidity in patients with schizophrenia is generally underrecognized. People suffering from schizophrenia are at increased risk of developing cardiovascular disease (CVD) and there is well advised to screen CVD and monitor patient`s physical health. Patients with schizophrenia are vulnerable to developing risk factors for cardiovascular disease, such as obesity, smoking, hypertension, dyslipidemia, and type 2 diabetes mellitus. there is an increasing concern that some antipsychotics prolong QT interval and this can result in torsedes de pointes and sudden death. There are other predisposing factors to drug-induced torsades de pointes including bradyvardia, electrolty imbalance, fernale sex and polyphramacy. Antipsychotic-induced torsades de pointes carries the risk of lethal consequences. Myocarditis and cardiomyopathy are rerely reported complications of antipsychotic treatment."@en . "3"^^ . "Kardiovaskul\u00E1rn\u00ED rizkika l\u00E9\u010Dby antipsychotiky"@cs . "Z(MSM0021620816)" . "CZ - \u010Cesk\u00E1 republika" . "3"^^ . "[FEBF08267F37]" . . "Remedia" . . .